right OFC for Obsessive-Compulsive Disorder
This trial will test if an accelerated schedule of theta-burst stimulation using a TMS device can help people with OCD who haven't responded to other treatments.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Does this trial accommodate those aged fifty or above?
"This medical trial is open to individuals 18-80 years of age. There are 23 studies for minors and 67 separate trials for seniors over 65."
Is it feasible to take part in this medical trial?
"The clinical trial is recruiting 180 individuals with a DSM-5 diagnosis of obsessive compulsive disorder (OCD) who have attained the age of majority but are below 80 years old. In order to qualify, they must display moderate severity in OCD as determined by their YBOCS score and demonstrate stable use of SRI medication for 8 weeks prior to joining the study. The candidates also need to have unsuccessfully gone through an APA approved first line treatment or rejected these treatments due to individual reasons, be able to provide informed consent, tolerate all required procedures, and pass screening forms at Stanford CNI without any contraindications."
Does this clinical trial still have participants available for enrollment?
"According to clinicaltrials.gov, recruitment for this medical study is still open. It was initially advertised on 15th January 2021 and the most recent update occurred during 20th December of the same year."
What are the desired results of this clinical investigation?
"The primary outcome measure of this clinical trial, assessed after the duration of treatment, is the percentage change in Yale-Brown Obsessive-Compulsive Scale (YBOCS). Secondary outcomes encompass changes from baseline functional connectivity to 1 month post-treatment via resting state fMRI between subcallosal cingulate and default mode network as well as within it. Furthermore, there will be a Percentage Change in Patient Health Questionnaire 9 (PHQ9) scores with higher scores representing greater severity, and finally a comparison between baseline and each day's treatment regarding functional connectivities."